CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 195 filers reported holding CHEMOCENTRYX INC in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,846,000 | +101.7% | 35,740 | -3.2% | 0.12% | +112.3% |
| Q2 2022 | $915,000 | -46.1% | 36,938 | -45.5% | 0.06% | -36.7% |
| Q1 2022 | $1,699,000 | -17.2% | 67,790 | +20.3% | 0.09% | -10.9% |
| Q4 2021 | $2,051,000 | +212.2% | 56,343 | +46.6% | 0.10% | +188.6% |
| Q3 2021 | $657,000 | +21.7% | 38,435 | -4.7% | 0.04% | +20.7% |
| Q2 2021 | $540,000 | -72.9% | 40,338 | +3.9% | 0.03% | -75.8% |
| Q1 2021 | $1,990,000 | – | 38,828 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
| Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
| Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
| HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
| Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
| Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
| Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
| Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
| RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
| Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |